Physician

Thomas E Dunlap, M.D.

According to 2025 Medicare claims, Thomas Dunlap, M.D. (NPI: 1932106002) practices cardiology in the Santa Rosa-Petaluma, CA market, with the plurality of this provider's patient population coming from Sonoma, CA. This provider's primary affiliated billing organization is PROVIDENCE MEDICAL FOUNDATION (NPI: 1740584473; TIN: 330185031) and primary practice location at 95476-6502. Dunlap is affiliated with the Health Connect Partners, LLC (ACO ID: A2342), participating under the MSSP model.

Dunlap's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,137 traditional Medicare patients, billed 8,981 HCPCS/CPT codes, and received $475,798 in Medicare payments. The top billing code was 93880 (Ultrasound of both sides of head and neck blood flow). Part D data shows 9,691 prescription claims across 926 beneficiaries totaling $3,044,852 in drug costs, led by Eliquis (Apixaban). DME data shows 12 claims. Open Payments data shows 35 records totaling $1,128. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $391,138 and ending at $475,798. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $566,521 to $3,044,852. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $2,156 and ending at $841.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,293	7,330	$391,138
2016	1,355	7,760	$382,391
2017	1,308	7,005	$334,230
2018	1,505	8,172	$386,682
2019	1,487	9,767	$616,279
2020	1,388	7,852	$550,167
2021	1,284	5,908	$401,856
2022	1,232	7,818	$535,140
2023	1,096	7,427	$480,201
2024	1,137	8,981	$475,798

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	619	3,900	$566,521
2016	644	3,622	$614,746
2017	680	3,574	$755,138
2018	748	3,900	$821,616
2019	963	5,822	$1,160,706
2020	1,291	7,536	$1,563,851
2021	1,403	9,323	$2,291,623
2022	1,086	9,668	$2,624,510
2023	974	9,854	$2,778,583
2024	926	9,691	$3,044,852

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$1,560
2016	N/R	32	$2,347
2017	N/R	60	$1,750
2018	N/R	32	$1,039
2019	N/R	38	$1,403
2020	N/R	55	$2,628
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	12	$841

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93880	Ultrasound of both sides of head and neck blood flow	280	280	$163
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	348	369	$149
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	405	644	$144
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	500	778	$98
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	656	1,354	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	654	45,648	$868,737
Entresto	Sacubitril/Valsartan	376	26,665	$520,285
Repatha Sureclick	Evolocumab	534	29,078	$468,211
Vyndamax	Tafamidis	16	480	$349,066
Farxiga	Dapagliflozin Propanediol	137	8,970	$161,934

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$841

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	35	$1,128	Edwards Lifesciences Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Thomas E. Dunlap, M.D.?

Tedicare shows public-source Medicare data for Thomas E. Dunlap, M.D. (NPI 1932106002), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas E. Dunlap, M.D. have ACO affiliation data?

Thomas E. Dunlap, M.D. is shown with ACO affiliation data for Health Connect Partners, LLC (MSSP, ACO ID A2342).

What billing organization is linked to Thomas E. Dunlap, M.D.?

Thomas E. Dunlap, M.D. is linked to PROVIDENCE MEDICAL FOUNDATION (billing NPI 1740584473) in the available physician profile data.

Does Thomas E. Dunlap, M.D. have Open Payments data?

Thomas E. Dunlap, M.D. has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.